KYDES Pharmaceuticals LLC is a Maryland-registered start-up pharmaceutical company with a vision to design scientifically sound and cost-effective pharmaceutical products based on the state-of-the-art knowledge and technologies. The company is committed to developing therapeutic advancements for diseases with unmet medical needs where it can improve efficacy, safety, and/or patient convenience/compliance. These high quality products, all containing known and/or approved drugs, will be produced for export to developing countries and for domestic market. The aim is to produce medicines in the US which will compete with products from overseas in terms of quality and cost. KYDES Pharmaceuticals will sub-contract some of the research and development as well as manufacturing operations. In addition, KYDES will create strategic, high-value partnerships with local and foreign pharmaceutical companies for the commercialization of the company’s drug candidates.
KYDES does not focus on any one product area. To optimize our market opportunities, we examine the development and regulatory approval of pharmaceutical products based on varying factors including market demand, ease of a regulatory approval, viability of commercialization and securing intellectual property rights, exclusivity and patents for our unique products.
KYDES’s long-term vision is to become known and respected by large pharmaceutical companies as the source for breakthrough pharmaceutical prescription products that address unmet medical needs in large segments of the population. Together with its pharmaceutical company partners, KYDES will endeavor to consistently capture significant market share for each of its products resulting in a growing stream of revenues via licensing fees and royalty payments. By developing a strong revenue base and by maintaining low operating costs, KYDES’s long term goal is to become a highly profitable company and achieve market valuations at or above comparable pharmaceutical product innovation companies.
KYDES has identified a strong management and advisory team with considerable knowledge and expertise in the development, clinical testing and commercialization of new pharmaceutical products, corporate operations, financing and management. It will engage outside consultants to assist with legal matters and securing regulatory approval for its product candidates.
KYDES will assemble a distinguished Advisory Board which will include experts relevant to each product as well as Business advisors.
The board is currently being reconstituted.
KYDES focuses its product development efforts on innovative prescription pharmaceuticals that treat medical conditions for which there is no commercially available solution and where there is a very large global market potential.
KYDES will protect its proprietary product rights via patents, copyrights, trademarks, confidentiality procedures and contractual provisions, as necessary.